E-7386 IS NOT A SPECIFIC CBP/β-CATENIN ANTAGONIST
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Our data show that E-7386 which has been reported to be a “first-in-class orally active CBP/beta-catenin modulator” anticancer agent, unfortunately by multiple criteria does not appear to be a bona fide CBP/β-catenin selective Comparative gene expression profiling analysis of RNA-seq data for SW480 treated with different CBP/β-catenin antagonists (ICG-001, C82, and E7386).
创建时间：
2024-01-15
